
GW 5074
CAS No. 220904-83-6
GW 5074( GW-5074 | GW5074 )
Catalog No. M13521 CAS No. 220904-83-6
A potent, selective c-Raf inhibitor with IC50 of 9 nM.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
2MG | 32 | In Stock |
![]() ![]() |
5MG | 49 | In Stock |
![]() ![]() |
10MG | 81 | In Stock |
![]() ![]() |
25MG | 122 | In Stock |
![]() ![]() |
50MG | 154 | In Stock |
![]() ![]() |
100MG | 186 | In Stock |
![]() ![]() |
200MG | 267 | In Stock |
![]() ![]() |
500MG | Get Quote | In Stock |
![]() ![]() |
1G | Get Quote | In Stock |
![]() ![]() |
Biological Information
-
Product NameGW 5074
-
NoteResearch use only, not for human use.
-
Brief DescriptionA potent, selective c-Raf inhibitor with IC50 of 9 nM.
-
DescriptionA potent, selective c-Raf inhibitor with IC50 of 9 nM; shows >1000-fold selectivity for raf kinase versus CDK1, CDK2, c-src, ERK2, MEK, p38, Tie2, VEGFR2, and c-Fms.
-
In Vitro——
-
In Vivo——
-
SynonymsGW-5074 | GW5074
-
PathwayMAPK/ERK Signaling
-
TargetRaf
-
RecptorC-Raf
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number220904-83-6
-
Formula Weight520.942
-
Molecular FormulaC15H8Br2INO2
-
Purity>98% (HPLC)
-
Solubility10 mM in DMSO
-
SMILESO=C1NC2=C(C=C(I)C=C2)/C1=C/C3=CC(Br)=C(O)C(Br)=C3
-
Chemical Name2H-Indol-2-one, 3-[(3,5-dibromo-4-hydroxyphenyl)methylene]-1,3-dihydro-5-iodo-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Lackey K, et al. Bioorg Med Chem Lett. 2000 Feb 7;10(3):223-6.
2. Yue X, et al. Eur J Pharmacol. 2006 Jul 1;540(1-3):57-9.
3. Jensen HA, et al. Cell Signal. 2015 Aug;27(8):1666-75.
molnova catalog



related products
-
BI 882370
BI 882370 is a highly potent, selective, orally active RAF inhibitor with IC50 of 0.4, 0.8 and 0.6 nM for BRAF V600E, BRAF WT and CRAF, respectively.
-
Lonafarnib
Lonafarnib is an orally bioavailable FPTase inhibitor for H-ras, K-ras-4B and N-ras with IC50 of 1.9 nM, 5.2 nM and 2.8 nM, respectively. Phase 3.
-
I-37
I-37 is a novel benzylamino substituted pyridopyrimidinone as SOS1 inhibitor.